Systemic exposure of pimecrolimus cream 1% and tacrolimus ointment 0.1% in adult patients with moderate to severe atopic dermatitis

被引：3
|
作者：
Draelos, ZD
Hanifin, J
Chon, K
机构：
[1] Dermatol Consulting Serv, High Point, NC USA
[2] Oregon Hlth Sci Univ, Dept Dermatol, Portland, OR 97201 USA
[3] Novartis Pharmaceut Corp, E Hanover, NJ USA
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2004年 / 50卷 / 03期
关键词：
D O I：
10.1016/j.jaad.2003.10.019
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
P13
引用
收藏
页码：P4 / P4
页数：1
相关论文
共 50 条
  • [31] Economic evaluation of tacrolimus ointment versus current care in moderate to severe atopic dermatitis
    Moeremans, K
    Annemans, L
    VALUE IN HEALTH, 2003, 6 (06) : 784 - 785
  • [32] Impact of secondary prophylactic use of tacrolimus 0.1% ointment on quality-of-life, treatment outcomes and costs in patients with moderate to severe atopic dermatitis
    Wollenberg, A.
    Sidhu, M.
    Odeyemi, I. A.
    Dorsch, B.
    Koehne-Volland, R.
    Schaff, M.
    Ehlken, B.
    Berger, K.
    VALUE IN HEALTH, 2007, 10 (06) : A467 - A468
  • [33] The effect of pimecrolimus cream 1% twice daily on pruritus in pediatric patients with mild to moderate atopic dermatitis
    Fowler, JF
    Johnson, A
    Abrams, K
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2004, 50 (03) : P62 - P62
  • [34] Pimecrolimus (SDZ ASM 981) cream 1% provides significant and rapid relief of pruritus in pediatric patients with moderate to severe atopic dermatitis
    Boguniewicz, M
    Eichenfield, L
    Ling, M
    Cherill, R
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2002, 119 (01) : 348 - 348
  • [35] Efficacy and safety of tacrolimus ointment compared with that of hydrocortisone butyrate ointment in adult patients with atopic dermatitis
    Reitamo, S
    Rustin, M
    Ruzicka, T
    Cambazard, F
    Kalimo, K
    Friedmann, PS
    Schoepf, E
    Lahfa, M
    Diepgen, TL
    Judodihardjo, H
    Wollenberg, A
    Berth-Jones, J
    Bieber, T
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2002, 109 (03) : 547 - 555
  • [36] Blood concentrations of pimecrolimus in adult patients with atopic dermatitis following intermittent administration of pimecrolimus cream 1% (Elidel®) for up to 1 year
    Van Leent, Edwin J. M.
    De Vries, Henry J. C.
    Ebelin, Marie-Eve
    Burtin, Pascale
    Scott, Graham
    Bos, Jan D.
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2007, 18 (01) : 19 - 22
  • [37] Eczema herpeticum during treatment of atopic dermatitis with 0.1% tacrolimus ointment
    Lübbe, J
    Pournaras, CC
    Saurat, JH
    DERMATOLOGY, 2000, 201 (03) : 249 - 251
  • [38] Eczema herpeticum during treatment of atopic dermatitis with tacrolimus ointment 0.1%
    Aguayo, Ingrid
    Salgueero, Irene
    Perez, Lucia
    Jaen, Pedro
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2009, 60 (03) : AB70 - AB70
  • [39] Tacrolimus ointment (TO) for adults with moderate to severe atopic dermatitis (AD): A dose escalation study.
    Kang, S
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1998, 110 (04) : 681 - 681
  • [40] Proactive use of tacrolimus 0.03% ointment in children with moderate or severe atopic dermatitis -: Outcomes and cost
    Thaci, D.
    Sidhu, M.
    Dorsch, B.
    Koehne-Volland, R.
    Ehlken, B.
    Berger, K.
    VALUE IN HEALTH, 2008, 11 (03) : A291 - A291
12345